Supplemental material
Leukemia & Lymphoma
Volume 60, 2019 - Issue 1
Open access
2,264
Views
7
CrossRef citations to date
0
Altmetric
Original Article: Clinical
Transfusion-free interval is associated with improved survival in patients with higher-risk myelodysplastic syndromes engaged in routine care
Jill A. BellMillennium Pharmaceuticals, Inc, (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited), Cambridge, MA, USA; Correspondence[email protected]
View further author information
, View further author information
Aaron GalaznikMillennium Pharmaceuticals, Inc, (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited), Cambridge, MA, USA; View further author information
, Marlo BlazerXcenda, LLC, Palm Harbor, Florida, USAView further author information
, Eileen FarrellyXcenda, LLC, Palm Harbor, Florida, USAView further author information
, Augustina OgbonnayaXcenda, LLC, Palm Harbor, Florida, USAView further author information
, Aditya RajuXcenda, LLC, Palm Harbor, Florida, USAView further author information
, Michael EaddyXcenda, LLC, Palm Harbor, Florida, USAView further author information
, Robert J. FramMillennium Pharmaceuticals, Inc, (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited), Cambridge, MA, USA; View further author information
& Douglas V. FallerMillennium Pharmaceuticals, Inc, (a wholly owned subsidiary of Takeda Pharmaceutical Company Limited), Cambridge, MA, USA; View further author information
show all
Pages 49-59
|
Received 19 Dec 2017, Accepted 04 Apr 2018, Published online: 22 Jun 2018
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.